Trials / Unknown
UnknownNCT02636244
Safety and Efficacy Study of SHAPE Gel in Alopecia Areata
A Multi-Center, Open-Label Phase 2 Study to Evaluate the Safety and Efficacy of SHAPE Gel, a Histone Deacetylase Inhibitor, in Patients With Alopecia Areata
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- TetraLogic Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of SHAPE Gel applied topically to adult patients with alopecia areata of the scalp.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHAPE Gel |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2017-08-01
- Completion
- 2018-01-01
- First posted
- 2015-12-21
- Last updated
- 2016-10-20
Source: ClinicalTrials.gov record NCT02636244. Inclusion in this directory is not an endorsement.